Peter Flynn

Peter Flynn

Company: Artiva Bio

Job title: Co-Founder & COO


Driving Progress in Solid Tumors: Outlining Barriers to Success and Next-Generation Approaches to Breach the Next Frontier in Cell Therapy 9:00 am

Describing barriers to efficacy in solid tumors for innate killer immune cells such as exhaustion, inhibition, persistence, and homing Examining the natural innate immune cell armoury against solid tumors, and features that can be enhanced by engineering or combination therapies Sharing early development strategies to breach solid tumor barriers with innate immune cell therapiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.